Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis / Pasero, D.; Sanna, S.; Liperi, C.; Piredda, D.; Branca, G. P.; Casadio, L.; Simeo, R.; Buselli, A.; Rizzo, D.; Bussu, F.; Rubino, S.; Terragni, P.. - In: INFECTION. - ISSN 0300-8126. - (2020). [10.1007/s15010-020-01561-x]
A challenging complication following SARS-CoV-2 infection: a case of pulmonary mucormycosis
Pasero D.
Writing – Original Draft Preparation
;Liperi C.;Casadio L.;Simeo R.;Buselli A.;Rizzo D.;Bussu F.;Rubino S.;Terragni P.
2020-01-01
Abstract
Severe acute respiratory syndrome coronavirus 2 infection might induce a significant and sustained lymphopenia, increasing the risk of developing opportunistic infections. Mucormycosis is a rare but severe invasive fungal infection, mainly described in immunocompromised patients. The first case of a patient diagnosed with coronavirus disease (COVID-19) who developed a pulmonary mucormycosis with extensive cavitary lesions is here reported. This case highlights how this new coronavirus might impair the immune response, exposing patients to higher risk of developing opportunistic infections and leading to worse outcomes.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
